Skip to main content

Table 4 Association of previously reported T2D loci with risk of GDM according to both criteria

From: Association between genetic risk variants and glucose intolerance during pregnancy in north Indian women

SNP

EA

Chr

Gene/nearest gene

Location

WHO 1999

WHO 2013

n

OR

CI(lower)

CI(upper)

p-value

OR

CI(lower)

CI(upper)

p-value

rs2296172

G

1

MACF1

coding-missense

0.92

0.71

1.20

0.56

1.04

0.89

1.21

0.58

3847

rs340874

C

1

PROX1

intergenic

0.94

0.80

1.11

0.52

0.96

0.87

1.06

0.47

3709

rs7578597

T

2

THADA

coding-missense

0.90

0.72

1.12

0.37

0.92

0.80

1.06

0.27

3710

rs243088

T

2

BCL 11A

intergenic

1.10

0.94

1.29

0.22

1.07

0.97

1.18

0.15

3717

rs7593730

T

2

RBMS1/ITGB6

intronic

1.01

0.84

1.22

0.83

0.99

0.88

1.11

0.93

3906

rs7607980

C

2

COBLL1

coding-missense

0.95

0.73

1.24

0.75

0.95

0.81

1.11

0.52

3885

rs13389219

C

2

GRB14

intergenic

1.25

1.03

1.52

0.022

1.11

0.99

1.23

0.058

3829

rs7578326

A

2

KIAA1486/IRS1

intron of uncharacterized LOC646736

0.97

0.80

1.18

0.78

0.98

0.87

1.10

0.79

3600

rs2943641

C

2

IRS1

intergenic

0.92

0.76

1.12

0.43

0.97

0.87

1.09

0.67

3643

rs4675095

A

2

IRS1

intron

1.11

0.87

1.42

0.39

1.04

0.90

1.19

0.58

3817

rs831571

C

3

PSMD6

intergenic

1.02

0.84

1.25

0.77

0.93

0.83

1.05

0.26

3726

rs4607103

C

3

ADAMTS9-AS2

intron

1.14

0.98

1.33

0.08

1.00

0.91

1.09

0.97

3884

rs11920090

T

3

SLC2A2

intron

1.19

0.93

1.51

0.16

1.16

1.01

1.33

0.03

3606

rs6815464

C

4

MAEA

intron

1.04

0.83

1.30

0.71

1.03

0.90

1.18

0.64

3722

rs459193

G

5

ANKRD55

intergenic

0.99

0.84

1.16

0.90

1.07

0.97

1.18

0.16

3884

rs4457053

G

5

ZBED3

intron of ZBED3-AS1

1.05

0.86

1.29

0.57

0.95

0.84

1.07

0.45

3579

rs9470794

C

6

ZFAND3

intron

1.07

0.85

1.35

0.51

1.05

0.91

1.21

0.48

3608

rs17168486

T

7

DGKB

intergenic

0.99

0.83

1.17

0.92

0.97

0.88

1.07

0.62

3855

rs2191349

T

7

DGKB/TMEM195

intergenic

1.04

0.88

1.22

0.62

1.00

0.91

1.10

0.95

3903

rs864745

T

7

JAZF1

intron

0.98

0.83

1.16

0.87

1.02

0.92

1.13

0.68

3876

rs4607517

A

7

GCK

intergenic

1.04

0.82

1.32

0.70

1.01

0.88

1.16

0.86

3903

rs17133918

C

7

GRB10

intron

1.03

0.87

1.23

0.67

0.97

0.88

1.08

0.65

3907

rs933360

A

7

GRB10

intron

1.03

0.87

1.22

0.70

1.03

0.93

1.14

0.54

3905

rs6943153

C

7

GRB10

intron

0.86

0.73

1.03

0.11

0.95

0.86

1.05

0.36

3602

rs516946

C

8

ANK1

intron

1.01

0.82

1.23

0.91

1.09

0.97

1.23

0.13

3922

rs896854

T

8

TP53INP1

intron

0.97

0.83

1.14

0.75

0.97

0.88

1.06

0.57

3903

rs7034200

A

9

GLIS3

intron

0.98

0.83

1.15

0.84

1.03

0.93

1.13

0.52

3868

rs13292136

C

9

TLE4 (CHCHD9)

intergenic

0.94

0.75

1.18

0.62

0.98

0.86

1.12

0.79

3706

rs12571751

A

10

ZMIZ1

intron

0.86

0.73

1.01

0.07

0.96

0.87

1.06

0.49

3601

rs553668

A

10

ADRA2A

UTR-3

1.17

0.99

1.39

0.06

1.07

0.97

1.19

0.15

3666

rs10885122

G

10

ADRA2A

intergenic

1.03

0.84

1.27

0.75

1.05

0.93

1.18

0.42

3683

rs163184

G

11

KCNQ1

intron

0.90

0.76

1.07

0.23

1.00

0.90

1.10

0.98

3713

rs2237895

C

11

KCNQ1

intron

0.96

0.81

1.13

0.66

1.01

0.92

1.11

0.79

3682

rs11605924

A

11

CRY2

intron

0.84

0.72

0.97

0.025

1.00

0.92

1.10

0.85

3909

rs7944584

A

11

MADD

intron

0.91

0.74

1.13

0.41

1.09

0.96

1.23

0.15

3553

rs174550

T

11

FADS1

intron

0.94

0.76

1.17

0.62

0.96

0.85

1.09

0.56

3908

rs1552224

A

11

CENTD2

intergenic

0.92

0.75

1.13

0.45

0.81

0.72

0.92

0.001

3911

rs11063069

G

12

CCND2

intergenic

0.99

0.80

1.23

0.98

1.04

0.91

1.19

0.52

3671

rs10842994

C

12

KLHDC5

intergenic

1.13

0.89

1.44

0.28

0.97

0.84

1.11

0.67

3906

rs1153188

A

12

DCD

intergenic

1.15

0.93

1.42

0.19

1.01

0.89

1.14

0.82

3912

rs1531343

C

12

HMGA2

intron of pseudogene

0.83

0.67

1.03

0.09

0.90

0.80

1.02

0.10

3915

rs7961581

C

12

TSPAN8,LGR5

intergenic

0.91

0.77

1.08

0.31

1.02

0.92

1.13

0.61

3703

rs7957197

T

12

OASL/TCF1/HNF1A

intron of QASL

0.87

0.65

1.17

0.37

1.00

0.83

1.21

0.96

3924

rs17271305

G

15

VPS13C

intron

1.02

0.86

1.20

0.81

0.92

0.83

1.02

0.15

3825

rs11071657

A

15

FAM148B

intergenic

1.03

0.87

1.22

0.72

0.92

0.83

1.02

0.13

3897

rs7177055

A

15

HMG20A

intergenic

1.00

0.85

1.17

0.99

0.98

0.89

1.08

0.74

3907

rs35767

G

12

IGF1

nearGene-5

0.88

0.91

1.10

0.19

0.93

0.94

1.06

0.21

3910

rs11634397

G

15

ZFAND6

intergenic

0.89

0.76

1.04

0.16

0.96

0.87

1.06

0.47

3910

rs8042680

A

15

PRC1

intron

0.89

0.76

1.04

0.16

0.99

0.90

1.10

0.95

3887

rs8090011

G

18

LAMA1

intron

0.95

0.81

1.11

0.57

0.93

0.84

1.02

0.13

3911

rs10401969

C

19

SUGP1

intron

0.96

0.72

1.27

0.79

0.86

0.72

1.01

0.07

3605

rs8108269

G

19

GIPR

intergenic

1.02

0.85

1.23

0.77

1.07

0.96

1.19

0.16

3508

rs10423928

A

19

GIPR

intron

0.85

0.67

1.08

0.20

1.06

0.93

1.20

0.37

3911

rs6017317

G

20

FITM2-R3HDML-HNF4A

intergenic

0.96

0.81

1.13

0.64

0.98

0.89

1.08

0.72

3758

rs5945326

A

X

DUSP9

intergenic

0.95

0.81

1.12

0.58

1.01

0.92

1.12

0.74

3589

  1. EA effect allele, OR_WHO1999 odds ratio based on WHO1999 criteria, OR_WHO2013 Odds ratio based on WHO2013 criteria, CI confidence interval
  2. significant p values where p < 0.05 are indicated in bold